Pascal and Francis Bibliographic Databases

Help

Search results

Your search

jo.\*:("Annals of oncology")

Filter

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 7130

  • Page / 286
Export

Selection :

  • and

'An ounce of prevention is worth a pound of cure': the case for and against GnRH-agonist for fertility preservationBLUMENFELD, Z; KATZ, G; EVRON, A et al.Annals of oncology. 2014, Vol 25, Num 9, pp 1719-1728, issn 0923-7534, 10 p.Article

A multicenter phase II study of pazopanib in patients with advanced gastrointestinal stromal tumors (GIST) following failure of at least imatinib and sunitinibGANJOO, K. N; VILLALOBOS, V. M; GEORGE, S et al.Annals of oncology. 2014, Vol 25, Num 1, pp 236-240, issn 0923-7534, 5 p.Article

A phase I/II study of lenalidomide in combination with sunitinib in patients with advanced or metastatic renal cell carcinomaRINI, B; REDMAN, B; GARCIA, J. A et al.Annals of oncology. 2014, Vol 25, Num 9, pp 1794-1799, issn 0923-7534, 6 p.Article

A phase III study evaluating the safety and efficacy of NEPA, a fixed-dose combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting over repeated cycles of chemotherapyGRALLA, R. J; BOSNJAK, S. M; HONTSA, A et al.Annals of oncology. 2014, Vol 25, Num 7, pp 1333-1339, issn 0923-7534, 7 p.Article

A randomized, phase II study of afatinib versus cetuximab in metastatic or recurrent squamous cell carcinoma of the head and neckSEIWERT, T. Y; FAYETTE, J; COHEN, E. E. W et al.Annals of oncology. 2014, Vol 25, Num 9, pp 1813-1820, issn 0923-7534, 8 p.Article

A rapid genetic counselling and testing in newly diagnosed breast cancer is associated with high rate of risk-reducing mastectomy in BRCA1/2-positive Italian womenCORTESI, L; RAZZABONI, E; FEDERICO, M et al.Annals of oncology. 2014, Vol 25, Num 1, pp 57-63, issn 0923-7534, 7 p.Article

An internally and externally validated prognostic score for metastatic breast cancer: analysis of 2269 patientsREGIERER, A. C; WOLTERS, R; UFEN, M. -P et al.Annals of oncology. 2014, Vol 25, Num 3, pp 633-638, issn 0923-7534, 6 p.Article

Association between CD8+ T-cell infiltration and breast cancer survival in 12 439 patientsALI, H. R; PROVENZANO, E; BOWDEN, S. J et al.Annals of oncology. 2014, Vol 25, Num 8, pp 1536-1543, issn 0923-7534, 8 p.Article

Best practices in the management of the psycho-oncologic aspects of head and neck cancer patients: recommendations from the European Head and Neck Cancer Society Make Sense CampaignREICH, M; LEEMANS, C. R; VERMORKEN, J. B et al.Annals of oncology. 2014, Vol 25, Num 11, pp 2115-2124, issn 0923-7534, 10 p.Article

Breaking bad news―what patients want and what they get: evaluating the SPIKES protocol in GermanySEIFART, C; HOFMANN, M; BÄR, T et al.Annals of oncology. 2014, Vol 25, Num 3, pp 707-711, issn 0923-7534, 5 p.Article

Coffee consumption and risk of nonaggressive, aggressive and fatal prostate cancer―a dose―response meta-analysisDISCACCIATI, A; ORSINI, N; WOLK, A et al.Annals of oncology. 2014, Vol 25, Num 3, pp 584-591, issn 0923-7534, 8 p.Article

Comprehensive gene expression meta-analysis of head and neck squamous cell carcinoma microarray data defines a robust survival predictorDE CECCO, L; BOSSI, P; LOCATI, L et al.Annals of oncology. 2014, Vol 25, Num 8, pp 1628-1635, issn 0923-7534, 8 p.Article

Continuing increased risk of oral/esophageal cancer after allogeneic hematopoietic stem cell transplantation in adults in association with chronic graft-versus-host diseaseATSUTA, Y; SUZUKI, R; KATO, K et al.Annals of oncology. 2014, Vol 25, Num 2, pp 435-441, issn 0923-7534, 7 p.Article

Distal and proximal colon cancers differ in terms of molecular, pathological, and clinical featuresMISSIAGLIA, E; JACOBS, B; ROTH, A. D et al.Annals of oncology. 2014, Vol 25, Num 10, pp 1995-2001, issn 0923-7534, 7 p.Article

ENCCA WP17-WP7 consensus paper on teenagers and young adults (TYA) with bone sarcomasWILHELM, M; DIRKSEN, U; BIELACK, S. S et al.Annals of oncology. 2014, Vol 25, Num 8, pp 1500-1505, issn 0923-7534, 6 p.Article

Early recognition of malnutrition and cachexia in the cancer patient: a position paper of a European School of Oncology Task ForceAAPRO, M; ARENDS, J; STRASSER, F et al.Annals of oncology. 2014, Vol 25, Num 8, pp 1492-1499, issn 0923-7534, 8 p.Article

Effect of adding gemtuzumab ozogamicin to induction chemotherapy for newly diagnosed acute myeloid leukemia: a meta-analysis of prospective randomized phase III trialsLI, X; XU, S. N; QIN, D. B et al.Annals of oncology. 2014, Vol 25, Num 2, pp 455-461, issn 0923-7534, 7 p.Article

Expression profiling stratifies mesothelioma tumors and signifies deregulation of spindle checkpoint pathway and microtubule network with therapeutic implicationsSURAOKAR, M. B; NUNEZ, M. I; RICE, D et al.Annals of oncology. 2014, Vol 25, Num 6, pp 1184-1192, issn 0923-7534, 9 p.Article

Factors influencing adherence to cancer treatment in older adults with cancer: a systematic reviewPUTS, M. T. E; TU, H. A; TOURANGEAU, A et al.Annals of oncology. 2014, Vol 25, Num 3, pp 564-577, issn 0923-7534, 14 p.Article

Final report of the phase I/II clinical trial of the E75 (nelipepimut-S) vaccine with booster inoculations to prevent disease recurrence in high-risk breast cancer patientsMITTENDORF, E. A; CLIFTON, G. T; HOLMES, J. P et al.Annals of oncology. 2014, Vol 25, Num 9, pp 1735-1742, issn 0923-7534, 8 p.Article

Final results of phase II trial of doxorubicin HCI liposome injection followed by bexarotene in advanced cutaneous T-cell lymphomaSTRAUS, D. J; DUVIC, M; HORWITZ, S. M et al.Annals of oncology. 2014, Vol 25, Num 1, pp 206-210, issn 0923-7534, 5 p.Article

Fracture incidence after 3 years of aromatase inhibitor therapyBOUVARD, B; SOULIE, P; TUCHAIS, C et al.Annals of oncology. 2014, Vol 25, Num 4, pp 843-847, issn 0923-7534, 5 p.Article

Incidence and time course of everolimus-related adverse events in postmenopausal women with hormone receptor-positive advanced breast cancer: insights from BOLERO-2RUGO, H. S; PRITCHARD, K. I; CHOUINARD, E et al.Annals of oncology. 2014, Vol 25, Num 4, pp 808-815, issn 0923-7534, 8 p.Article

Long-term treatment efficacy in primary inflammatory breast cancer by hormonal receptor- and HER2-defined subtypesMASUDA, H; BREWER, T. M; WOODWARD, W. A et al.Annals of oncology. 2014, Vol 25, Num 2, pp 384-391, issn 0923-7534, 8 p.Article

Maintenance bevacizumab-pemetrexed after first-line cisplatin-pemetrexed-bevacizumab for advanced nonsquamous nonsmall-cell lung cancer: updated survival analysis of the AVAPERL (M022089) randomized phase III trialBARLESI, F; SCHERPEREEL, A; PAZZOLA, A et al.Annals of oncology. 2014, Vol 25, Num 5, pp 1044-1052, issn 0923-7534, 9 p.Article

  • Page / 286